QLT Inc (QLTI)

1.38
NASDAQ : Health Care
Prev Close 1.38
Day Low/High 0.00 / 0.00
52 Wk Low/High 1.22 / 3.96
Avg Volume 173.10K
Exchange NASDAQ
Shares Outstanding 52.83M
Market Cap 73.96M
EPS -0.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Stocks Turn Lower After Yellen Expresses Confidence in U.S. Economy

Stocks Turn Lower After Yellen Expresses Confidence in U.S. Economy

Stocks give back gains Wednesday afternoon as Federal Reserve Chair Janet Yellen expresses her confidence in the strength of the U.S. economy.

Wall Street Rises as It Awaits Fed, Crude Comes Off Lows

Wall Street Rises as It Awaits Fed, Crude Comes Off Lows

Stocks hold gains by mid-morning Wednesday as investors await news on interest rates from the Federal Reserve.

Stock Futures Hold Gains as Industrial Production Falls

Stock Futures Hold Gains as Industrial Production Falls

Stock futures signal a Wall Street rebound on Wednesday after four days of losses as investors await news from the Federal Reserve.

QLT, Aegerion Merge Two Troubled Biotechs

QLT, Aegerion Merge Two Troubled Biotechs

Normally, investors get excited when two biotech companies announce a merger. The exception is when the merger is more about desperation than transformation.

5 Breakout Stocks Under $10 Set to Soar

5 Breakout Stocks Under $10 Set to Soar

These under-$10 stocks are within range of triggering big breakout trades.

QLT Announces First Quarter 2016 Results

QLT Announces First Quarter 2016 Results

Provides Synthetic Retinoid Program Update

QLT Terminates $20 Million Private Placement

QLT Terminates $20 Million Private Placement

Decision Avoids Unnecessary Shareholder Dilution

QLT Inc. Completes Enrollment In Its Natural History Study

QLT Inc. Completes Enrollment In Its Natural History Study

A Retrospective Study of Visual Function in Subjects with Inherited Retinal Disease Caused by Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Gene Mutations

QLT Announces Third Quarter 2015 Results

QLT Announces Third Quarter 2015 Results

Provides Update on Synthetic Retinoid Program

InSite Vision Determines That An Unsolicited Offer From A Global Pharmaceutical Company To Acquire InSite For $0.35 Per Share In Cash Constitutes A

InSite Vision Determines That An Unsolicited Offer From A Global Pharmaceutical Company To Acquire InSite For $0.35 Per Share In Cash Constitutes A "Company Superior Proposal"

InSite Vision Inc. (OTCBB:INSV) today announced that InSite's Board of Directors has determined that the previously announced unsolicited offer from a global pharmaceutical company (the "Bidder") to acquire all outstanding...

InSite Vision And QLT Amend Merger Agreement

InSite Vision And QLT Amend Merger Agreement

InSite Vision Inc. (OTCBB: INSV) today announced that InSite and QLT Inc.

InSite Vision To Merge With Canadian Biotechnology Company QLT

InSite Vision To Merge With Canadian Biotechnology Company QLT

InSite Vision Inc. (OTCBB: INSV) today announced that it has reached a definitive agreement with QLT Inc.